Brief: Neurizon Therapeutics Says Firm Commitments To Raise A$7.1 Million Via Placement
23/12/2025 01:13
Dec 23 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX: FIRM COMMITMENTS TO RAISE A$7.1 MILLION VIA PLACEMENT AT A$0.08 PER SHARE Further company coverage: NUZ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility